Remove Government Remove Pharma R&D Remove Regulations
article thumbnail

EFPIA states AI rules must “enable not hinder” pharma R&D

Drug Discovery World

The Federation added: “It is critical that the regulatory frameworks governing the use of AI in research, development and manufacture must be fit-for-purpose, risk-based, non-duplicative, globally aligned, and adequately tailored.